Back
Intellia Therapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
29
NTLA
Intellia Therapeutics
Last Price:
15.77
Seasonality Move:
12.78%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.21 | Sell |
| 20-day SMA: | 16.97 | Sell |
| 50-day SMA: | 18.87 | Sell |
| 200-day SMA: | 23.46 | Sell |
| 8-day EMA: | 16.33 | Sell |
| 20-day EMA: | 16.84 | Sell |
| 50-day EMA: | 18.6 | Sell |
| 200-day EMA: | 23.49 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 42.72 | Sell |
| Chaikin Money Flow: | -2062488 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.13 - 19.47) | Sell |
| Bollinger Bands (100): | (18.1 - 24.6) | Sell |
Intellia Therapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 16.11 while NTLA 8-day simple moving average is 16.21, which is a Sell signal.
- The stock price of NTLA is 16.11 while Intellia Therapeutics 20-day SMA is 16.97, which makes it a Sell.
- Intellia Therapeutics 50-day simple moving average is 18.87 while NTLA share price is 16.11, making it a Sell technically.
- NTLA stock price is 16.11 and Intellia Therapeutics 200-day simple moving average is 23.46, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $16.11. The Score for NTLA is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
1.64B
Price in USD:
16.11
Share Volume:
2.1M
Intellia Therapeutics 52-Week Range
52-Week High:
34.87
52-Week Low:
13.95
Sell
29
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 16.11 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 16.11 while NTLA 8-day exponential moving average is 16.33, which is a Sell signal.
- The stock price of NTLA is 16.11 while Intellia Therapeutics 20-day EMA is 16.84, which makes it a Sell.
- Intellia Therapeutics 50-day exponential moving average is 18.60 while NTLA share price is 16.11, making it a Sell technically.
- NTLA stock price is 16.11 and Intellia Therapeutics 200-day simple moving average is 23.49, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.08 per share, and a decrease next year of $0.17 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting Intellia Therapeutics is a Sell
- Intellia Therapeutics Relative Strength Index (RSI) is 42.72, which suggest Intellia Therapeutics is oversold
- The Bollinger Bands (25) for Intellia Therapeutics is (15.13 - 19.47), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (18.1 - 24.6), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.